144 related articles for article (PubMed ID: 34419484)
1. Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entry.
Tanaka T; Okuyama-Dobashi K; Motohashi R; Yokoe H; Takahashi K; Wiriyasermkul P; Kasai H; Yamashita A; Maekawa S; Enomoto N; Ryo A; Nagamori S; Tsubuki M; Moriishi K
Antiviral Res; 2021 Oct; 194():105165. PubMed ID: 34419484
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening.
Kirstgen M; Müller SF; Lowjaga KAAT; Goldmann N; Lehmann F; Alakurtti S; Yli-Kauhaluoma J; Baringhaus KH; Krieg R; Glebe D; Geyer J
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452354
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.
Shimura S; Watashi K; Fukano K; Peel M; Sluder A; Kawai F; Iwamoto M; Tsukuda S; Takeuchi JS; Miyake T; Sugiyama M; Ogasawara Y; Park SY; Tanaka Y; Kusuhara H; Mizokami M; Sureau C; Wakita T
J Hepatol; 2017 Apr; 66(4):685-692. PubMed ID: 27890789
[TBL] [Abstract][Full Text] [Related]
4. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
Fukano K; Oshima M; Tsukuda S; Aizaki H; Ohki M; Park SY; Wakita T; Wakae K; Watashi K; Muramatsu M
J Virol; 2021 Nov; 95(24):e0093821. PubMed ID: 34613794
[TBL] [Abstract][Full Text] [Related]
5. Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation.
Fauzyah Y; Ono C; Torii S; Anzai I; Suzuki R; Izumi T; Morioka Y; Maeda Y; Okamoto T; Fukuhara T; Matsuura Y
Antiviral Res; 2021 Feb; 186():104999. PubMed ID: 33346055
[TBL] [Abstract][Full Text] [Related]
6. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
7. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
8. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
9. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).
Watashi K; Sluder A; Daito T; Matsunaga S; Ryo A; Nagamori S; Iwamoto M; Nakajima S; Tsukuda S; Borroto-Esoda K; Sugiyama M; Tanaka Y; Kanai Y; Kusuhara H; Mizokami M; Wakita T
Hepatology; 2014 May; 59(5):1726-37. PubMed ID: 24375637
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
12. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity.
Wang XJ; Hu W; Zhang TY; Mao YY; Liu NN; Wang SQ
Antiviral Res; 2015 Aug; 120():140-6. PubMed ID: 26086883
[TBL] [Abstract][Full Text] [Related]
13. Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors.
Goh B; Choi J; Kang JA; Park SG; Seo J; Kim TY
J Pharm Biomed Anal; 2020 Jan; 178():112959. PubMed ID: 31722821
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
[TBL] [Abstract][Full Text] [Related]
15. Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle.
Blanchet M; Sureau C; Labonté P
Antiviral Res; 2014 Jun; 106():111-5. PubMed ID: 24717262
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.
Nio Y; Akahori Y; Okamura H; Watashi K; Wakita T; Hijikata M
Biochem Biophys Res Commun; 2018 Jun; 501(3):820-825. PubMed ID: 29723527
[TBL] [Abstract][Full Text] [Related]
17. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
[TBL] [Abstract][Full Text] [Related]
18. Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses.
Kobayashi C; Watanabe Y; Oshima M; Hirose T; Yamasaki M; Iwamoto M; Iwatsuki M; Asami Y; Kuramochi K; Wakae K; Aizaki H; Muramatsu M; Sureau C; Sunazuka T; Watashi K
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458494
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide.
Okuyama-Dobashi K; Kasai H; Tanaka T; Yamashita A; Yasumoto J; Chen W; Okamoto T; Maekawa S; Watashi K; Wakita T; Ryo A; Suzuki T; Matsuura Y; Enomoto N; Moriishi K
Sci Rep; 2015 Nov; 5():17047. PubMed ID: 26592202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
